Jade Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-7.9M | $-7.9M | — | $58.0K |
| FY2021 | $-27.4M | $-27.6M | $181.0K | $2.0M |
| FY2022 | $-39.1M | $-39.3M | $195.0K | $5.5M |
| FY2023 | $-56.8M | $-56.9M | $142.0K | $11.9M |
| FY2024 | $-71.2M | $-71.2M | — | $11.3M |
| FY2025 | $-94.7M | $-94.9M | $196.0K | $20.0M |